Risk factors
Vicarious Surgical (RBOT) risk factors
Item 1A of every Vicarious Surgical Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors62 risks3 new2 dropped7 reworded
Vicarious Surgical transitioned to the OTCID market tier after being suspended and delisted from the NYSE.
Filed Mar 09, 2026 - FY2024 10-K risk factors61 risks
Vicarious Surgical has $48.8 million in cash and short-term investments funding operations only into the first quarter of 2026. The company has earned zero revenues and accumulated a deficit of $195.9 million since inception. The Vicarious Surgical System faces regulatory, clinical development, manufacturing, and intensive market competition risks.
Filed Mar 17, 2025